UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

26 Jul 2005

CIMZIA(TM) demonstrates significant positive results in its two pivotal phase III Crohn's disease trials

Read More
25 Jul 2005

UCB Receives Positive Opinion from European Authorities for Orphan Designation of Brivaracetam for the Treatment of Progressive Myoclonic Epilepsies

Read More
20 Jul 2005

UCB Confirms Solid First Half Zyrtec Sales in USA

Read More
6 Jul 2005

UCB sells its food diagnostics business to Neogen

Read More
29 Jun 2005

Positive opinion for UCB's Xyrem® for the treatment of cataplexy in adults with narcolepsy

Read More
24 Jun 2005

FDA Approves UCB's Keppra® for Use in Childhood Epilepsy

Read More

Stay up-to-date on the latest news and information from UCB